Evidence map›Paper›PMID 30519238›Full record

ArticleFrontiers in immunology2018

Identification of a HIV Gp41-Specific Human Monoclonal Antibody With Potent Antibody-Dependent Cellular Cytotoxicity.

Zheng Yang, Xi Liu, Zehua Sun, Jingjing Li, Weiguo Tan, Weiye Yu, Meiyun Zhang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Zheng YangDepartment of Tuberculosis Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen, China.
Xi LiuDepartment of Infectious Diseases, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
Zehua SunNational Jewish Health, Denver, CO, United States.
Jingjing LiAIDS Institute, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
Weiguo TanDepartment of Tuberculosis Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen, China.
Weiye YuDepartment of Tuberculosis Prevention, Shenzhen Center for Chronic Disease Control, Shenzhen, China.
Meiyun ZhangAIDS Institute, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
Shenzhen Nanshan Center for Chronic Disease Control · CNUniversity of Hong Kong · HKNational Jewish Health · USSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibody-Dependent Cellular Cytotoxicity (ADCC) is a major mechanism of protection against viral infections

Indexed as

AIDS VaccinesAntibodies, MonoclonalAntibody-Dependent Cell CytotoxicityB-LymphocytesCells, CulturedEpitopes, B-LymphocyteFlow CytometryHIV-1HIV AntibodiesHIV Envelope Protein gp41HIV InfectionsHumansImmunity, HumoralPeptidesSingle-Cell AnalysisAIDS VaccinesAntibodies, MonoclonalEpitopes, B-LymphocyteHIV AntibodiesHIV Envelope Protein gp41PeptidesADCCantibodyepitopegp41HIVMPER

Identifiers

PMID30519238
PMCPMC6251304
OpenAlexW2901921930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.